Literature DB >> 15273082

Hazard ratio in clinical trials.

Spotswood L Spruance1, Julia E Reid, Michael Grace, Matthew Samore.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15273082      PMCID： PMC478551          DOI： 10.1128/AAC.48.8.2787-2792.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.

Authors:  S L Spruance; S K Tyring; B DeGregorio; C Miller; K Beutner
Journal:  Arch Intern Med       Date:  1996 Aug 12-26

2.  A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

Authors:  S K Tyring; J M Douglas; L Corey; S L Spruance; J Esmann
Journal:  Arch Dermatol       Date:  1998-02

3.  Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis.

Authors:  J C Huff; J L Drucker; A Clemmer; O L Laskin; J D Connor; Y J Bryson; H H Balfour
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

4.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

5.  Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; H Weiss; J W Gnann; S Tyring; G J Mertz; P G Pappas; C J Schleupner; F Hayden; J Wolf; S J Soong
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391

6.  Regression modelling strategies for improved prognostic prediction.

Authors:  F E Harrell; K L Lee; R M Califf; D B Pryor; R A Rosati
Journal:  Stat Med       Date:  1984 Apr-Jun       Impact factor: 2.373

7.  Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.

Authors:  M J Wood; R Kay; R H Dworkin; S J Soong; R J Whitley
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

8.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391
  8 in total
  118 in total

1.  Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse.

Authors:  Joseph W Ditre; Bryan W Heckman; Lisa R LaRowe; Jessica M Powers
Journal:  Nicotine Tob Res       Date:  2021-01-07       Impact factor: 4.244

2.  Long-term prognostic value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis.

Authors:  Valeria Cantoni; Roberta Green; Wanda Acampa; Mario Petretta; Domenico Bonaduce; Marco Salvatore; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2016-01-12       Impact factor: 5.952

3.  Prognostic role of D-dimer in patients with lung cancer: a meta-analysis.

Authors:  Xuelei Ma; Yanyan Li; Jing Zhang; Jingwen Huang; Lei Liu
Journal:  Tumour Biol       Date:  2013-10-10

4.  Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease.

Authors:  Thomas J Langan; Amy L Barcykowski; Jonathan Dare; Erin C Pannullo; Leah Muscarella; Randy L Carter
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

5.  Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.

Authors:  David A Wolk; Carl Sadowsky; Beth Safirstein; Juha O Rinne; Ranjan Duara; Richard Perry; Marc Agronin; Jose Gamez; Jiong Shi; Adrian Ivanoiu; Lennart Minthon; Zuzana Walker; Steen Hasselbalch; Clive Holmes; Marwan Sabbagh; Marilyn Albert; Adam Fleisher; Paul Loughlin; Eric Triau; Kirk Frey; Peter Høgh; Andrea Bozoki; Roger Bullock; Eric Salmon; Gillian Farrar; Christopher J Buckley; Michelle Zanette; Paul F Sherwin; Andrea Cherubini; Fraser Inglis
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

Review 6.  Treatment on advanced NSCLC: platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials.

Authors:  Jian-Guo Zhou; Xu Tian; Xue Wang; Jin-Hui Tian; Yi Wang; Fei Wang; Yu Zhang; Hu Ma
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

7.  Nanos gigantium humeris insidentes: the awarded Cox proportional hazards model.

Authors:  Luca Bertolaccini; Alessandro Pardolesi; Fabio Davoli; Piergiorgio Solli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 8.  Physical risk factors for developing non-specific neck pain in office workers: a systematic review and meta-analysis.

Authors:  Deokhoon Jun; Michaleff Zoe; Venerina Johnston; Shaun O'Leary
Journal:  Int Arch Occup Environ Health       Date:  2017-02-21       Impact factor: 3.015

9.  Reinstitutionalization following psychiatric discharge among VA patients with serious mental illness: a national longitudinal study.

Authors:  Cheryl Irmiter; John F McCarthy; Kristen L Barry; Soheil Soliman; Frederic C Blow
Journal:  Psychiatr Q       Date:  2007-12

Review 10.  Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.

Authors:  John L Moran; Petra L Graham; Sue Rockliff; Andrew D Bersten
Journal:  Crit Care       Date:  2010-07-13       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.